Highlights:
- SK bioscience of South Korea has received European Union Good Manufacturing Practices (GMP) certification.
- The certification will approve the production and processing line and quality check system of the COVID-19 vaccines.
- SK biosciences have a license agreement with Novavax to produce 40 million COVID-19 vaccines for South Korea.
SK biosciences....
Tags : COVID-19, vaccine, South Korea, Healthcare, pandemic,
comments (0)